Magnetic resonance spectroscopy for evaluation of suspected brain tumor. [electronic resource] - TEC bulletin Mar 2003 - 23-6 p. digital

Publication Type: Journal Article

1543-1622


Blue Cross Blue Shield Insurance Plans
Brain Neoplasms--diagnosis
Device Approval
Drug Approval
Evidence-Based Medicine
Humans
Insurance Coverage
Magnetic Resonance Spectroscopy
Outcome Assessment, Health Care
Protons
Technology Assessment, Biomedical
United States
United States Food and Drug Administration